Concepedia

Peter M. Burch

PM

13

Publications

784

Citations

13

H-Index

1997

Active since

Affiliations

Pfizer (United States)(Current)

Newcastle University

Yale University

Critical Path Institute

University of Vermont

Peter M. Burch is an author at Pfizer (United States) specializing in medicine, physiology, and mechanobiology.

Top concepts

Publications per year

1997–2019

13

Publications

13

Redox-Dependent Expression of Cyclin D1 and Cell Proliferation by Nox1 in Mouse Lung Epithelial Cells

Priya Ranjan, Vikas Anathy, Peter M. Burch et al. · Antioxidants and Redox Signaling · 2006 · 126 citations

A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys

Michael St. Andre, M. Catherine Johnson, Prashant Bansal et al. · Skeletal Muscle · 2017 · 98 citations · Full text

Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy

Peter M. Burch, Oksana Pogoryelova, Richard A. Goldstein et al. · Journal of Neuromuscular Diseases · 2015 · 97 citations · Full text

An Extracellular Signal-Regulated Kinase 1- and 2-Dependent Program of Chromatin Trafficking of c-Fos and Fra-1 Is Required for Cyclin D1 Expression during Cell Cycle Reentry

Peter M. Burch, Ziqiang Yuan, A. H. Loonen et al. · Molecular and Cellular Biology · 2004 · 89 citations · Full text

, , +17

Gain-of-function/Noonan syndrome SHP-2/ <i>Ptpn11</i> mutants enhance calcium oscillations and impair NFAT signaling

Per Uhlén, Peter M. Burch, Christina Ivins Zito et al. · Proceedings of the National Academy of Sciences · 2006 · 86 citations · Full text

Rows per page

1–5 of 13